Funded by the Gates Foundation, the report titled “Leading Innovations Enabling Health Product Access in Africa’‘, finds that, amid difficult macro- economic realities and dwindling investment in African technology ecosystems, a select number of African health innovators are emerging as leaders.

Having operated for 10 years on average, the 24 leading innovators collectively now partner with 100+ manufacturers and 75 public health institutions, reaching around 50,000 providers (who serve hundreds of thousands of patients per day) and delivering health products to millions of consumers directly.

Kasha made news capturing Series B investment last year, and has since gone on to build its health technology access platform and report annual revenues of more than $50 million in 2023 – the highest ever recorded by Salient’s research to date.

Like Kasha, innovators that offer digitally-enabled Order and Inventory Management services to hospitals, clinics, pharmacies and drug shops appear dominant amongst the leading companies, making up 13 of the 24 featured innovations, with operations in 30 countries.

Four leading Online Pharmacies are reaching nearly 10 million customers and generating median annual revenues of nearly $9M.

The other categories featured are innovations in Product Protection and Visibility, Medical Drone Delivery and Data Analytics.

While leading innovators now appear positioned to deliver more substantive impact, they require targeted engagement from governments, donors, industry and global health institutions to transform access for unserved populations and improve the cost-effectiveness of care.

To leverage leading innovators’ models in driving increases in access, governments, industry, donors and global health agencies should: simplify regulatory pathways; explore innovators’ ability to generate cost- savings for health systems, pursuing partnerships when the evidence is strong; and evolve contracting and payment systems to enable innovators to partner in healthcare delivery systems at larger scale.

The 24 leading innovators featured are (in alphabetical order):

1. Chefaa,
2. DrugStoc,
3. Field Inc,
4. Figorr,
5. Grinta,
6. HealthPlus,
7. Kasha,
8. LifeBank,
9. Maisha Meds,
10. Meditect,
11. mPedigree,
12. MYDAWA,
13. Pendulum,
14. PharmaSecure,
15. Remedial Health,
16. RxAll,
17. Sobrus,
18. Sproxil,
19. Talamus Health,
20. VIA Global Health,
21. Viebeg,
22. Wingcopter,
23. Yodawy and
24. Zipline.

Speaking on the launch of the report, Yomi Kazeem, engagement manager at Salient Advisory, commented:

‘’The findings underscore the remarkable resilience and growing impact of African supply chain innovators. Having tracked healthtech startups for many years, the emergence of a group of leading innovators is exciting to report. Local and global public health communities must increasingly recognize and leverage the innovators in developing reliable and resilient health supply chains.”

Ann Allen, Senior Program Officer at Gates Foundation, commented:

“Technology-enabled innovations have the potential to help reverse long-running challenges in African health systems, while creating local jobs and strengthening local health markets. The report confirms innovators are increasingly positioned to deliver on this promise. However, there is more to be done as leveraging these innovations to truly transform cost-effective access for millions of unserved Africans will require concerted efforts from governments, industry and global health agencies alike.”

To download the full market intelligence report, please click here.

Investing in Innovation Africa (i3), a pan-African initiative for start-ups building the future of healthcare supply chains, has announced its second cohort of 29 companies.

Funded by the Bill & Melinda Gates Foundation and sponsored by Cencora (formerly AmerisourceBergen), Merck Sharpe & Dohme (MSD), Microsoft, and Chemonics, i3 is dedicated to facilitating the commercialization of promising early- and growth-stage companies.

Selected startups receive introductions to leading potential customers in industry, donor agencies and governments, a $50,000 grant, and tailored investment readiness support from leading accelerators Villgro Africa, IMPACT Lab, Startupbootcamp Afritech, and CcHUB.

The 29 start-ups chosen operate in 21 different African countries, delivering digitally-enabled healthcare supply chain solutions. Innovators are building online pharmacies and telemedicine firms, as well as inventory management services for pharmacies, clinics and hospitals, supply chain data analytics, product protection, product visibility and more.

Thirty-eight (38%) of the companies selected are women-led and 17% are conducting operations in Francophone Africa.

The selected companies are, in alphabetical order: Afia Group Limited, Aimcare Health, Bena Care, BioCertica, Chari Pharma, CheckUps Medical, Chefaa, Dawa Mkononi, Drugstore Nigeria, Famasi Limited, Field Intelligence, Inc, GICMED, Grinta, Healthtracka, Kapsule, Medical Diagnostech, Medpharma Alliance International Limited, Octosoft Technologies Limited, Pharmarun, Pharmaserv Health Project Nigeria Limited, Reductiona, SASA Health Limited, Tech Care For All Eastern Africa, Technovera – Pelebox Smart Lockers, Tibu Health, UltraTeb, Waspito, WellaHealth, and Welo.

Innovators selected will benefit from the i3’s annual Access to Markets event in Nairobi, which will be held between 14-15 of November.

The event facilitates dynamic partnership dialogues between industry stakeholders, governments, donors, and large multilateral agencies. Connections are made to drive the commercialization and scale of the start-ups through mutually beneficial contracts, pilot projects, and investments.

The first cohort of 31 companies supported by i3 last year forged 24 contracts, pilots, and strategic partnerships to date.

Kieran Daly, Director, Global Health Agencies and Funds at the Bill and Melinda Gates Foundation, commented: “As countries and global health institutions work to expand access to priority products, we face an urgent need to leverage solutions across the public and private sectors to improve health outcomes and strengthen local health systems. Programs like i3 help us understand, support and engage with technology-driven solutions emerging across Africa, hand-in-hand with our partners.”

Yusuf Rasool, Director, Global Market Access, Sustainable Access Solutions at MSD, noted, “We are excited to have a second cohort of 29 innovative changemakers in African healthcare enter the program. Investing in these companies are a means of delivering lifesaving solutions and empowering communities through the access of critical medicines across the continent.”

Jason Dinger, Senior Vice President of Global Products and Solutions at Cencora

“The range of startups selected for the second cohort reflects the breadth of talent and creativity in the

African entrepreneurial landscape, and we look forward to witnessing the transformative impact of their solutions in the years to come.”

Investing in Innovation Africa (i3) is coordinated by Salient Advisory and SCIDaR and is operationalized by leading technology hubs across the continent: CCHub for West Africa, Startupbootcamp AfriTech for Southern Africa, IMPACT Lab for North and French-speaking Africa, and Villgro Africa for East Africa.

The round was co-led by Raed Ventures and Nclude, with participation from investors including Silicon Valley-based Endeavor Catalyst and 500 Global, bringing its total funding to date to $9.5 million. 

Grinta is focused on ensuring efficiency in the pharmaceutical supply chain by empowering independent pharmacies. The end-to-end platform offers a seamless and easy-to-use experience, giving access to the full spectrum of traceable pharmaceutical and medical products from multiple vendors in addition to providing fulfillment, demand planning, and inventory financing. To achieve its goal, the company is working with all stakeholders across the value chain, manufacturers, distributors, wholesalers, and pharmacies.

Egypt has strong local manufacturers, three large distributors and more than 3,000 wholesalers all targeting 60,000 fragmented retail pharmacies that are yet to be digitised, which makes it the largest pharmaceuticals market in Africa with a size surpassing $6 billion. 

Mohamed Azab, co-founder and CEO of Grinta said, “We are very excited to have the right investor base as our backers that share the same values and vision of making Pharma accessible and affordable across Africa. As we plan to expand our footprint in the main Pharma hubs on the continent, we will also enable Egyptian and regional Pharma manufacturers to further penetrate the $50 billion African market.”

Azab added that since inception in 2021, Grinta has acquired two companies, PH Store, a similar digital platform in northern Egypt, and EME, a software development company with a solid tech team. As a result, the company expanded aggressively across seven governorates in Egypt, with over 14,000 registered pharmacies on its platform, 20,000+ SKUs and has delivered more than 100,000 orders over the last year.

Grinta is founded by serial Mohamed Azab, Yosra Badr, Ali Youssef, and Hamza Mohamed, who are active members of the regional entrepreneurship ecosystem and have successfully built and scaled several healthcare companies over the last 12 years across Africa. The founders have attracted impact-driven top talents across all verticals and reached approximately 300 employees.

“Grinta is an exceptional team of serial healthcare entrepreneurs on a mission to improve access to and affordability of medicines in Egypt and Africa,” commented Wael Nafee, Partner at Raed Ventures. 

“By empowering pharmacies to be more efficient at running their business, fixing a broken supply chain end-to-end, and partnering with all stakeholders in the value chain they will realise this vision. We’re proud to be doubling down on Grinta for this funding round as they expand across Africa.”

“We’re excited to partner with Grinta to help enable their vision of delivering customer-centric, data-driven, and fintech-enabled solutions to modernise the pharmaceutical supply chain in Egypt and beyond,” said Eslam Darwish, Founding General Partner at Nclude. 

“We look forward to supporting the Grinta team on their journey to build a digital and cashless bridge between underserved individual pharmacy owners and all stakeholders across the pharma value chain.” 

“Grinta represents our 10th investment in Egypt, making Endeavor Catalyst proudly one of the most active international investors in the country. But more than attracting attention and capital to the region, Mohamed Azab’s latest achievement advances the entire healthcare industry,” said Endeavor Catalyst Managing Partner Allen Taylor. 

“As an Endeavor Entrepreneur and Board Member, we have witnessed how Azab’s multiplier effect has impacted the local ecosystem. Our recent mapping showed that he alone has already inspired, invested, and mentored more than 100 local businesses in the Middle East, and this is only the beginning. We are huge fans of Azab and his team, knowing they can lead the next frontier of innovation in Egypt.”